{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:02:25Z","timestamp":1777518145428,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T00:00:00Z","timestamp":1374105600000},"content-version":"vor","delay-in-days":778,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.rmed.2011.01.009","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T15:16:18Z","timestamp":1299510978000},"page":"946-949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations"],"prefix":"10.1016","volume":"105","author":[{"given":"D.J.","family":"Serisier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2011.01.009_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolised recombinant human DNase 1","volume":"113","author":"O\u2019Donnell","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2011.01.009_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.01.009_bib3","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1378\/chest.130.5.1503","article-title":"Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis","volume":"130","author":"Bilton","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2011.01.009_bib4","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.rmed.2008.06.005","article-title":"Effects of long-term low-dose azithromycin in patients with non-CF bronchiectasis","volume":"102","author":"Anwar","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2011.01.009_bib5","first-page":"540","article-title":"Prophylactic antibiotic treatment of bronchiectasis with azithromycin","volume":"59","author":"Davies","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2011.01.009_bib6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease-modifying effects of twice weekly oral azithromycin in bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.rmed.2011.01.009_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1183\/09031936.00042208","article-title":"Long-term macrolide therapy in chronic inflammatory airway diseases","volume":"33","author":"Crosbie","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2011.01.009_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00044011-199816020-00009","article-title":"A phase I determination of azithromycin in plasma during a 6-week period in normal volunteers after a standard dose of 500\u00a0mgs once daily for 3 days","volume":"16","author":"Cokaert","year":"1998","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.rmed.2011.01.009_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study","volume":"369","author":"Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2011.01.009_bib10","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/jac\/dkh469","article-title":"Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14","volume":"54","author":"Dias","year":"2004","journal-title":"J Antimicr Chemother"},{"key":"10.1016\/j.rmed.2011.01.009_bib11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s15010-001-1072-3","article-title":"Influence of macrolide antibiotics on promotion of resistance in oral flora of children","volume":"29","author":"Kastner","year":"2001","journal-title":"Infection"},{"key":"10.1016\/j.rmed.2011.01.009_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.99.13236199","article-title":"A pilot study of low-dose erythromycin in bronchiectasis","volume":"13","author":"Tsang","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2011.01.009_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/MCP.0b013e328312ed8c","article-title":"Update on non-cystic fibrosis bronchiectasis","volume":"14","author":"Bilton","year":"2008","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.rmed.2011.01.009_bib14","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.01.009_bib15","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement in survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.01.009_bib16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1165\/ajrcmb.25.4.4552","article-title":"Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics","volume":"25","author":"Gorrini","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmed.2011.01.009_bib17","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1164\/ajrccm.156.1.9612065","article-title":"Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells","volume":"156","author":"Takizawa","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.01.009_bib18","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1183\/09031936.95.08091451","article-title":"Effect of erythromycin on Haemophilus influenzae endotoxin- induced release of IL-6, IL-8 and sICAM-1 by cultured human bronchial epithelial cells","volume":"8","author":"Khair","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2011.01.009_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1440-1843.2007.01227.x","article-title":"Erythromycin attenuates MUC5AC synthesis and secretion in cultured human tracheal cells infected with RV14","volume":"13","author":"Inoue","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2011.01.009_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.200212-1437OC","article-title":"In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells","volume":"168","author":"Shimizu","year":"2003","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611111000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611111000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:11:36Z","timestamp":1760613096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611111000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0954611111000242"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2011.01.009","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term, low-dose erythromycin in bronchiectasis subjects with frequent infective exacerbations","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2011.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}